NF1 and cancer: Individuals from our centre have a rather high standardised incidence rate for cancers compared to other centres in Europe, as pointed out in a recent study comparing cancer in NF1 patients both with and without an NF1-microdeletion (Kallionpää et al., manuscript in preparation).